Cite
HARVARD Citation
Lupu‐Haber, Y. et al. (2019). Pretreating Mesenchymal Stem Cells with Cancer Conditioned‐Media or Proinflammatory Cytokines Changes the Tumor and Immune Targeting by Nanoghosts Derived from these Cells. Advanced healthcare materials. 8 (10), p. n/a. [Online].